Michigan Medicine

Ann Arbor, Michigan 48109-5212

7 studies enrolling now · 55 studies all time

What they study most

Aging, Alzheimer Disease, Amyotrophic Lateral Sclerosis, Anticoagulant Therapy, Appendicitis (Diagnosis), Asthma, Atrial Fibrillation, Bacterial Disease Carrier, Brain Concussion, COVID-19 Pandemic, COVID-19 Vaccines, Caregiver Burden

Studies at this site

Diagnosing Epilepsy To EffeCT Change — Recruiting now
Vitamin K for Perioperative Warfarin Management — Recruiting now
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders — Recruiting now
NPA-OSA Device Tolerability, Usability and Acclimation Clinical Study in Adult Obstructive Sleep Apnea (OSA) Patients — Recruiting now
Precision Antibiotic Dosing for Appendectomy — Recruiting now
Long-term Evaluation of a Nasopharyngeal Airway — Recruiting now
Clinical Trial for Surgery of the Ulnar Nerve (SUN) at the Elbow — Recruiting now
A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) — Running, not enrolling
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes — Running, not enrolling
A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy — Running, not enrolling
A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa — Completed
The Caffeine, Postoperative Delirium, and Change in Outcomes After Surgery (CAPACHINOS-2) Study — Completed
A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout — Completed
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma — Running, not enrolling
Getting to Yes, Michigan! (G2YMI) — Completed
Digital Youth-Nominated Support Team (YST) Program — Completed
Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses — Completed
Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM — Completed
An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome — Running, not enrolling
Natural History Study of Exocrine Pancreatic Function in Infants With Cystic Fibrosis (CF) — Completed
Improving Communication and Healthcare Outcomes for Patients With Communication Disabilities — Completed
Better Lithotripsy and Ureteroscopy Evaluation of Stenting (BLUES) — Completed
Safety and Efficacy of HSK3486 Compared to Propofol for Induction of General Anesthesia in Adults With Elective Surgery — Completed
Psychosocial Pain Management to Improve Opioid Use Disorder Treatment Outcomes — Completed
How do the Neck Muscles Influence Head Acceleration During Sport-associated Impact Events in High School Athletes? — Completed
Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease — Running, not enrolling
Trial of ERapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance — Running, not enrolling
A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS) — Stopped early
Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients — Completed
MENDD Tolerance Assessment Study — Stopped early
A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF) — Completed
Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed
A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031) — Stopped early
A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation — Completed
Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy — Completed
Studying Students at Risk for COVID-19 — Completed
A Study Evaluating the Long-term Safety of VX-445 Combination Therapy — Completed
Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis — Completed
Phase 1 In-vivo Biliary Study of KSP/QRH Heptapeptide Dimer — Stopped early
A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) — Completed
Serum and Urine Titanium Levels in Children With Early Onset Scoliosis Treated With Growth-Sparing Instrumentation — Completed
Monitoring Health Care Workers at Risk for COVID-19 Using Wearable Sensors and Smartphone Technology — Completed
A Phase 2 Study to Evaluate Efficacy and Safety of VX-561 in Subjects Aged 18 Years and Older With Cystic Fibrosis — Completed
A Study Evaluating the Long Term Safety and Efficacy of VX-659 Combination Therapy — Stopped early
Caffeine and Neurologic Recovery Following Surgery and General Anesthesia — Completed
Inherited Risk Evaluation Tool (InheRET): Identifying Patients at Increased Risk for Hereditary Disease — Status unconfirmed
A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes) — Completed
A Pilot Study of the Utility of 3D Printed Masks for ALS Subjects — Stopped early
Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis — Stopped early
Feasibility of Immediate Postpartum Long-acting Reversible Contraception Implementation — Completed